Cerebellar Agenesis is a rare condition characterized by the absence or underdevelopment of the cerebellum, the part of the brain responsible for motor control and coordination. The ICD10 code for Cerebellar Agenesis is Q04.3. Unfortunately, there is no specific ICD9 code for Cerebellar Agenesis as the ICD9 system does not have a direct equivalent. It is important to consult with a healthcare professional for accurate diagnosis and appropriate coding.
Cerebellar Agenesis is a rare condition characterized by the absence or underdevelopment of the cerebellum, the part of the brain responsible for coordinating voluntary movements, balance, and posture. Although the exact cause is often unknown, it may result from genetic mutations, prenatal infections, or certain environmental factors.
In the International Classification of Diseases, 10th Revision (ICD-10), Cerebellar Agenesis is classified under code Q04.0. This code falls within Chapter XVII: Congenital malformations, deformations, and chromosomal abnormalities. Specifically, Q04.0 denotes "Cerebellar malformation" and is further categorized as "Agenesis, cerebellar."
On the other hand, in the previous edition, the International Classification of Diseases, 9th Revision (ICD-9), Cerebellar Agenesis was not specifically assigned a unique code. However, it was commonly classified under the broader category of "Congenital anomalies of the nervous system" using code 742.59. This code encompassed various other malformations of the central nervous system, including cerebellar agenesis.
It is important to note that the ICD coding system is regularly updated to reflect advances in medical knowledge and provide more specific diagnoses. Therefore, the transition from ICD-9 to ICD-10 has allowed for a more detailed classification of conditions, aiding in accurate diagnosis, treatment, and research.
Remember, if you have any health concerns or questions regarding a specific diagnosis, it is essential to consult with a qualified healthcare professional for personalized advice and guidance.